Expert committee of India’s drug regulator gave the green light to the drug tirzepatide

By

 On November 08, 2023, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

Zepbound activates receptors of hormones secreted from the intestine (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) to reduce appetite and food intake. Zepbound is administered by injection under the skin once weekly, and the dosage must be increased over four to 20 weeks to achieve the target dosages of 5 milligram (mg), 10 mg or 15 mg once weekly. The maximum dosage of Zepbound is 15 mg once weekly.

Zepbound can cause side effects such as nausea, diarrhea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic) reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease.

Zepbound received Priority Review and Fast Track designations for this indication.

The FDA granted this approval to Eli Lilly and Co.

  1. U.S. Food and Drug Administration ( FDA )
  2. The Indian Express

Comments

Post a Comment

Popular posts from this blog

Russian parliament passed a bill to revoke its ratification of the Comprehensive Test Ban Treaty

By
Relevance:  Russia revokes ratification of nuclear test ban treaty (CTBT) - ICAN But it affirmed that it will  retain its cooperation with the treaty’s verification system and implementing organisation.  Comprehensive Test Ban Treaty: The Comprehensive Test Ban Treaty (CTBT), which opened for signature in 1996, was intended to prohibit all nuclear weapon test explosions. Over 2,000 nuclear tests occurred between 1945 and 1996: the United States (1,000+), the Soviet Union (700+), France (200+), the United Kingdom and China (45 each). As at January 2013, 183 countries had signed the Treaty, of which 158 have also ratified it, including three of the nuclear weapon states (France, the Russian Federation and the United Kingdom). However, 44 specific nuclear technology holder countries must sign and ratify before the CTBT can enter into force. Of these, eight are still missing: China, Egypt, India , Iran, Israel, North Korea, Pakistan and the US. India , North Korea and Pakista...
Read more

Interstellar space and Interstellar Probes ( Voyager and New Horizons Missions )

By
Interstellar Space: Interstellar space is often called the space between the stars, but more specifically, it’s the region between our Sun’s heliosphere and the astrospheres of other stars. Our heliosphere is a vast bubble of plasma – a gas of charged particles – that spews out of the Sun. This outflow is known as the solar wind. The bubble surrounds the Sun and stretches beyond the planets. Both Voyager spacecraft had to travel more than 11 billion miles (17 billion kilometers) from the Sun in order to cross the edge of the heliosphere. This bubble is moving through interstellar space as the Sun orbits the center of the Milky Way galaxy. As our heliosphere plows through space, it creates a bow wave, like the wave formed by the bow of a ship. Kuiper Belt &  Oort Cloud: The Kuiper Belt is a doughnut-shaped ring of icy objects around the Sun, extending just beyond the orbit of Neptune from about 30 to 55 AU. Similar to the asteroid belt, the Kuiper Belt is a region of leftovers f...
Read more

ISRO developing semi-cryogenic engine working on LOX Kerosene propellant

By
ISRO is developing a 2000 kN thrust semi-cryogenic engine working on an LOX Kerosene propellant combination for enhancing the payload capability of LVM3 and for future launch vehicles. Liquid Propulsion Systems Centre (LPSC) is the lead centre for the development of semi-cryogenic propulsion systems with the support of other launch vehicle centres of ISRO. The assembly and testing of the propulsion modules were done at the ISRO propulsion complex (IPRC), Mahendragiri. As part of the engine development, a pre-burner ignition test article, which is a full complement of the engine power head system excluding the turbopumps is realized. The first ignition trial was conducted successfully on May 2, 2024, at semi cryo integrated engine test facility (SIET) at IPRC, Mahendragiri, which was dedicated to the nation recently by the honorable Prime Minister of India. Smooth and sustained ignition of the preburner is demonstrated which is vital for the starting of the semi-cryogenic engine. Semi-c...
Read more